David E. Zembower
- Toxicology top 1%
- Bioactive Compounds and Antitumor Agents 2
- Organic Chemistry top 5%
- Carbohydrate Chemistry and Synthesis 5
- Click Chemistry and Applications 2
- Pharmacology top 10%
-
- Cancer therapeutics and mechanisms 5
- Natural product bioactivities and synthesis 4
-
- HIV/AIDS drug development and treatment 6
-
- Toxin Mechanisms and Immunotoxins 2
-
- Analytical Chemistry and Chromatography 2
- Co-authors
- Lance StewartAlex B. BurginMark CushmanYves PommierM.D. FeeseBart L. StakerHeping ZhangMichael T. Flavin
- Journals
- Journal of Medicinal Chemistry (7 papers)Bioorganic & Medicinal Chemistry Letters (6 papers)Organic Process Research & Development (3 papers)
- Partner nations
- United StatesAustraliaIceland
In The Last Decade
David E. Zembower
26 papers receiving 1.0k citations
Peers
Comparison fields: 5 of 80
- Toxicology 195
- Organic Chemistry 481
- Pharmacology 170
- Molecular Biology 645
- Virology 32
Countries citing papers authored by David E. Zembower
This map shows the geographic impact of David E. Zembower's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David E. Zembower with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David E. Zembower more than expected).
Fields of papers citing papers by David E. Zembower
This network shows the impact of papers produced by David E. Zembower. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David E. Zembower. The network helps show where David E. Zembower may publish in the future.
Co-authorship network
The 25 scholars most cited alongside David E. Zembower, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2012 | 8 | |
| 2 | 2010 | 1 | |
| 3 | 2009 | 34 | |
| 4 | 2009 | 3 | |
| 5 | 2009 | 99 | |
| 6 | 2009 | 18 | |
| 7 | 2005 | 446 | |
| 8 | 2002 | 2 | |
| 9 | 1999 | 26 | |
| 10 | 1999 | 2 | |
| 11 | 1998 | 51 | |
| 12 | 1998 | 40 | |
| 13 | 1998 | 62 | |
| 14 | 1997 | 64 | |
| 15 | 1996 | 11 | |
| 16 | 1996 | 29 | |
| 17 | 1993 | 17 | |
| 18 | 1993 | 24 | |
| 19 | 1992 | 32 | |
| 20 | 1988 | 6 |
About David E. Zembower
David E. Zembower is a scholar working on Toxicology, Organic Chemistry, Biochemistry, Biological Psychiatry and Pharmacology, having authored 26 papers that have together received 1.1k indexed citations. Recurring topics across this work include HIV/AIDS drug development and treatment (6 papers), Cancer therapeutics and mechanisms (5 papers), Carbohydrate Chemistry and Synthesis (5 papers), Natural product bioactivities and synthesis (4 papers), Bioactive Compounds and Antitumor Agents (2 papers), Toxin Mechanisms and Immunotoxins (2 papers), Analytical Chemistry and Chromatography (2 papers) and Click Chemistry and Applications (2 papers). The work is most often cited by research in Toxicology (195 citations), Organic Chemistry (481 citations), Pharmacology (170 citations), Molecular Biology (645 citations) and Virology (32 citations). David E. Zembower has collaborated with scholars based in United States, Australia and Iceland. Frequent co-authors include Lance Stewart, Alex B. Burgin, Mark Cushman, Yves Pommier, M.D. Feese, Bart L. Staker, Heping Zhang, Michael T. Flavin, Matthew M. Ames and Ze‐Qi Xu. Their work appears in journals such as Journal of Medicinal Chemistry, Bioorganic & Medicinal Chemistry Letters, Organic Process Research & Development, Synthesis and Journal of Pharmacology and Experimental Therapeutics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.